Product

[Mirror] Quadratic Arithmetic Programs: from Zero to Hero

Source Node:
Time Stamp: February 2, 2024 10:43 AM - Modified On: February 2, 2024 - Published By:
Source Cluster:
Republished By Plato

Vitalik Buterin via the Vitalik Buterin Blog This is a mirror of the post at https://medium.com/@VitalikButerin/quadratic-arithmetic-programs-from-zero-to-hero-f6d558cea649 There has been a lot of interest lately in the technology behind zk-SNARKs, and people are increasingly trying to demystify something that many have come to call "moon math" due to its perceived sheer indecipherable complexity. zk-SNARKs are indeed quite challenging to grasp, especially due to the sheer number of moving parts that need to come together for the whole thing to work, but if we break the technology down piece by piece then

Plato Data Intelligence Leverages Vectara to Power its Data-As-A-Service / DaaS Platform

Source Node:
Time Stamp: January 18, 2024 1:36 PM - Modified On: January 18, 2024 - Published By:
Source Cluster:
Republished By Plato

From development to launch, Vectara’s GenAI technology and team help innovators get to market faster. The announced partnership breaks new ground towards deploying a next generation of GenAI tools with Vertical focus. Vectara, the Trusted Generative AI Product Platform, and Plato Data Intelligence, creators of PlatoAi, have entered into a commercial agreement to unlock the power of Vectara via Plato AI’s Generative Intelligence platform. With an emphasis on secure, trustworthy, and transparent GenAI for enterprises, Vectara was the clear choice for developers who want a trusted provider to count on

Bracket Labs Announces $2 Million Pre-Seed Raise to Support the Launch of its ‘Passages’ Trading Platform

Source Node:
Time Stamp: January 4, 2024 2:04 PM - Modified On: January 4, 2024 - Published By:
Source Cluster:
Republished By Plato

PANAMA CITY FLA – January 4, 2024 – Bracket Labs completed a $2 million pre-seed fundraise round to support the launch of "Passage," a volatility trading product available on the project’s BracketX trading platform. The debut of the range-bound product makes trading long and short volatility entirely on-chain easy for traders of all levels. In June 2023, Bracket Labs completed Binance Labs’ Season 5 Incubation Program and received investment from Binance Labs. In addition to completing the Incubation Program, Bracket Labs completed its pre-seed investment round from other notable crypto

NKGen Biotech Advances Alzheimer’s Treatment with SNK01: First Patient Dosed in Phase 1/2a Trial

Source Node:
Time Stamp: December 29, 2023 3:07 AM - Modified On: December 29, 2023 - Published By:
Source Cluster:
Republished By Plato

December 29, 2023 - NKGen Biotech, Inc. (Nasdaq: NKGN) is making strides in Alzheimer's disease (AD) treatment with the dosing of the first patient in its Phase 1/2a trial for SNK01, an autologous natural killer (NK) cell therapy. The innovative product, designed for moderate AD, has demonstrated promising results in neuroinflammation and cognitive function during its Phase 1 safety trial. Key Points: SNK01 Efficacy: NKGen's SNK01, a cryopreserved autologous NK cell therapy, showed improvement in neuroinflammation and cognitive function in the Phase 1 dose-escalation safety trial. The therapy boasts enhanced

GPO Plus, Inc. (GPOX) Achieves Record Revenues with 25% Quarterly Growth

Source Node:
Time Stamp: December 18, 2023 1:36 PM - Modified On: December 18, 2023 - Published By:
Source Cluster:
Republished By Plato

December 18, 2023 - GPO Plus, Inc. (OTCQB: GPOX), a prominent distribution and manufacturing company specializing in consumer products for convenience stores, gas stations, and specialty retailers, has reported impressive Q2 financial results. The company's gross revenue for the quarter ending October 31, 2023, reached a record $1.21 million, marking a substantial 25% increase from the previous quarter ending July 31, 2023, which reported $970,735 in gross revenues. Key Highlights: Quarterly Revenue Surge: GPOX achieved a remarkable 25% surge in top-line revenue, reaching $1.213 million in the second quarter, up

Verofax wins GITEX Supernova Web3 & Blockchain Award 2023

Source Node:
Time Stamp: October 31, 2023 2:23 PM - Modified On: October 31, 2023 - Published By:
Source Cluster:
Republished By Plato

DUBAI, Nov 1, 2023 - (ACN Newswire) - Verofax, an innovator in Brand & Retail solutions, was selected among 521 startups globally as the best solution offering for Web3 & Blockchain, at the GITEX 2023 Expo,  Supernova Challenge in Dubai. Verofax, a UAE-based startup and service provider for turning shopping & products interactive, has emerged as the winner of the 2023 Supernova Challenge at Expand North Star Dubai, the world's largest startup event. The startup received the prize after rounds of pitching against global finalists. Verofax's groundbreaking solution combines interactive Product

BANTgo and Verofax Team Up to Revolutionize E-waste Collection Through Tokenized Rewards

Source Node:
Time Stamp: October 24, 2023 7:04 AM - Modified On: October 24, 2023 - Published By:
Source Cluster:
Republished By Plato

DUBAI, Oct 24, 2023 - (ACN Newswire) - In an ambitious stride towards environmental sustainability, BANTgo and Verofax have announced a pioneering collaboration to enhance e-waste collection. The groundbreaking partnership seeks to galvanize the masses into responsible recycling by rewarding their endeavors with tokenized incentives. Verofax, was awarded the GITEX Supernova Web3 and Blockchain award, introduces its innovative technology to this eco-initiative. The venture encompasses the deployment of advanced smart bins explicitly designed for e-waste collection. These bins are equipped with a validation system to ensure accurate assessment of the

Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases

Source Node:
Time Stamp: October 13, 2023 5:17 AM - Modified On: October 13, 2023 - Published By:
Source Cluster:
Republished By Plato

  In the United States, heart disease accounts for a significant number of deaths every year, with cardiovascular disease being the primary concern. Factors like lifestyle choices and unforeseen circumstances contribute to its prevalence. Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the heart's lining) are two inflammatory heart conditions primarily linked to immunological reactions from viral infections and mRNA vaccines. Though considered rare, awareness of these conditions is growing, especially among younger populations. Recent research in Science Immunology highlighted an increase in cytokine production leading to myocarditis

Revolutionizing Tourism with Web3: A Landmark Partnership Between Camino Network, DCM Swiss, 1World Online, and Web3-Solutions

Source Node:
Time Stamp: October 12, 2023 12:02 PM - Modified On: October 12, 2023 - Published By:
Source Cluster:
Republished By Plato

In an unprecedented-opportunity-driven move, four innovative companies in the travel and marketing sectors — Camino Network, initiated by Chain4Travel, DCM Swiss, 1World Online, and Web3-Solutions — have come together to announce a landmark partnership. This alliance aims to harness cutting-edge technologies in reshaping the future of travel and tourism experiences and bringing new monetization options and benefits to all ecosystem participants. We are happy to announce that: DCM Swiss and 1World Online are becoming Validators at Camino Network. Web3-Solutions becomes a Regional Partner of DCM: A regional partnership agreement has

Nutriband’s Innovative Patent Breaks New Ground in Transdermal Medications

Source Node:
Time Stamp: September 20, 2023 8:36 AM - Modified On: September 20, 2023 - Published By:
Source Cluster:
Republished By Plato

Revolutionary AVERSA™ Technology Sets New Standard for Opioid Patch Safety ORLANDO, FL / September 20, 2023 - Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW), a leading developer of transdermal pharmaceutical products, proudly announces the issuance of a U.S. patent for its cutting-edge AVERSA™ Technology. This groundbreaking innovation, utilizing taste aversion, marks a paradigm shift in addressing the primary routes of abuse associated with opioid-based transdermal patches. The newly granted patent, numbered U.S. patent 11,759,431, titled "Abuse and Misuse Deterrent Transdermal Systems," significantly bolsters Nutriband's intellectual property protection in the United States. It covers

American Picture House Corporate Update

Source Node:
Time Stamp: September 6, 2023 4:28 PM - Modified On: September 6, 2023 - Published By:
Source Cluster:
Republished By Plato

New York, NY, Raleigh, NC, and Los Angeles, CA.  September 6, 2023 – American Picture House Corporation (OTC: APHP), an entertainment company with a focus on producing feature films, limited series, and entertainment enhancing technologies, today provided a corporate update for shareholders. Industry Strikes American Picture House supports the ideals behind the two current industry strikes -- brought by the Writers Guild of America (“WGA”) and the Screen Actors Guild (“SAG”) -- and joins the many reasonable voices urging for a fair and timely resolution. Update on Feature Films -